Vol. 2 No. 4 (2025)

Research Articles

Meta-analysis on Vitamin D Receptor TaqI Polymorphism and Breast Cancer Risk

Published 2025-08-31

  • Shan Zhou
    • ,
  • Faqing Tang

Shan Zhou
Department of Clinical Laboratory and Hunan Key Laboratory of Oncotarget gene, Hunan Cancer Hospital, 
and The affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.

Faqing Tang
Department of Clinical Laboratory and Hunan Key Laboratory of Oncotarget gene, Hunan Cancer Hospital, 
and The affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.

Abstract

Vitamin D receptor (VDR) principally mediates the anticancer activities of vitamin D. Many studies investigated the association between VDR gene TaqI polymorphism and breast cancer, but the results were inconclusive. We performed this meta-analysis to evaluate the association between VDR gene TaqI polymorphism and breast cancer. 21 studies with a total of 10232 cancer cases and 11708 control subjects were identified from PubMed, Embase, Ovid Medline and CNKI databases. The pooled odds ratio (OR) and confidence intervals (95 % CI) were used to assess the association. The meta-analysis indicated that VDR gene TaqI polymorphism was associated with risk of breast cancer (T vs. t, OR = 0.94, 95 % CI 0.91–0.98, p = 0.004; TT vs. tt, OR = 0.88, 95 % CI 0.80–0.95, p = 0.002; TT vs. Tt, OR = 0.98, 95 % CI 0.92–1.04, p = 0.445; TT vs. Tt+tt OR = 0.95, 95 % CI 0.90–1.01, p = 0.078; TT+Tt vs. tt, OR = 0.89, 95% CI .82-0.96, p = 0.002). Subgroup analysis by ethnicity further showed the polymorphism of VDR TaqI was a potential risk factor for breast cancer in the Caucasian population (OR T vs. t = 0.94, 95 % CI 0.91–0.98, p = 0.004; OR TT vs. tt = 0.88, 95%CI 0.81–0.97, p = 0.002).

Keywords

vitamin D receptor, polymorphism, breast cancer, meta-analysis

PDF

References

  1. Samuel S, Sitrin MD (2008) Vitamin D's role in cell proliferation and differentiation. Nutr Rev 66: S116-124.
  2. DeLuca HF (2004) Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80: 1689s-1696s.
  3. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
  4. D'Aurizio F, Villalta D, Metus P, Doretto P, Tozzoli R (2015) Is vitamin D a player or not in the pathophysiology of autoimmune thyroid diseases? Autoimmun Rev 14: 363-369.
  5. Mehta RG, Peng X, Alimirah F, Murillo G, Mehta R (2013) Vitamin D and breast cancer: emerging concepts. Cancer Lett 334: 95-100.
  6. Pickholtz I, Saadyan S, Keshet GI, Wang VS, Cohen R, et al. (2014) Cooperation between BRCA1 and vitamin D is critical for histone acetylation of the p21waf1 promoter and growth inhibition of breast cancer cells and cancer stem-like cells. Oncotarget 5: 11827-11846.
  7. Selvaraj P, Prabhu Anand S, Harishankar M, Alagarasu K (2009) Plasma 1,25 dihydroxy vitamin D3 level and expression of vitamin d receptor and cathelicidin in pulmonary tuberculosis. J Clin Immunol 29: 470-478.
  8. Ogunkolade BW, Boucher BJ, Prahl JM, Bustin SA, Burrin JM, et al. (2002) Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes 51: 2294-2300.
  9. Zmuda JM, Cauley JA, Ferrell RE (2000) Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev 22: 203-217.
  10. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, et al. (2015) Global cancer statistics, 2012. CA Cancer J Clin 65: 87-108.
  11. Saccone D, Asani F, Bornman L (2015) Regulation of the vitamin D receptor gene by environment, genetics and epigenetics. Gene 561: 171-180.
  12. Friedrich M, Rafi L, Mitschele T, Tilgen W, Schmidt W, et al. (2003) Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer. Recent Results Cancer Res 164: 239-246.
  13. Raimondi S, Johansson H, Maisonneuve P, Gandini S (2009) Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis 30: 1170-1180.
  14. Serrano D, Gnagnarella P, Raimondi S, Gandini S (2015) Meta-analysis on vitamin D receptor and cancer risk: focus on the role of TaqI, ApaI, and Cdx2 polymorphisms. Eur J Cancer Prev.
  15. Gandini S, Gnagnarella P, Serrano D, Pasquali E, Raimondi S (2014) Vitamin D receptor polymorphisms and cancer. Adv Exp Med Biol 810: 69-105.
  16. Yang B, Liu S, Yang X, Wang Y, Zhao X, et al. (2014) Current evidence on the four polymorphisms of VDR and breast cancer risk in Caucasian women. Meta Gene 2: 41-49.
  17. Andraos C, Koorsen G, Knight JC, Bornman L (2011) Vitamin D receptor gene methylation is associated with ethnicity, tuberculosis, and TaqI polymorphism. Hum Immunol 72: 262-268.
  18. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
  19. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. Bmj 327: 557-560.
  20. Zhang K, Song L (2014) Association between vitamin D receptor gene polymorphisms and breast cancer risk: a meta-analysis of 39 studies. PLoS One 9: e96125.
  21. Xu Y, He B, Pan Y, Deng Q, Sun H, et al. (2014) Systematic review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Tumour Biol 35: 4153-4169.
  22. Wang H, Wang W, Yang D, Wang S (2014) TaqI polymorphism of VDR gene contributes to breast cancer risk. Tumour Biol 35: 93-102.
  23. Lee YH, Song GG (2014) Vitamin Dreceptor FokI, BsmI, ApaI, and TaqI polymorphisms and the susceptibility to breast cancer: ameta-analysis. Neoplasma 61: 607-616.
  24. Huang QQ, Liao YY, Ye XH, Fu JJ, Chen SD (2014) Association between VDR polymorphisms and breast cancer: an updated and comparative meta-analysis of crude and adjusted odd ratios. Asian Pac J Cancer Prev 15: 847-853.
  25. Wang J, He Q, Shao YG, Ji M, Bao W (2013) Associations between vitamin D receptor polymorphisms and breast cancer risk. Tumour Biol 34: 3823-3830.
  26. Reimers LL, Crew KD, Bradshaw PT, Santella RM, Steck SE, et al. (2015) Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk. Cancer Causes Control 26: 187-203.
  27. Nemenqani DM, Karam RA, Amer MG, Abd El Rahman TM (2015) Vitamin D receptor gene polymorphisms and steroid receptor status among Saudi women with breast cancer. Gene 558: 215-219.
  28. Abd-Elsalam EA, Ismaeil NA, Abd-Alsalam HS (2015) Vitamin D receptor gene polymorphisms and breast cancer risk among postmenopausal Egyptian women. Tumour Biol.
  29. Mishra DK, Wu Y, Sarkissyan M, Sarkissyan S, Chen Z, et al. (2013) Vitamin D receptor gene polymorphisms and prognosis of breast cancer among African-American and Hispanic women. PLoS One 8: e57967.
  30. Huang Y, Lu H, Bai Y, Chen Y, Zeng Y, et al. (2012) Relationship between genptypes and haplotypes of Vitamin D receptor gene and breast cancer risk. Zhonghua Liu Xing Bing Xue Za Zhi: 89–92.
  31. Engel LS, Orlow I, Sima CS, Satagopan J, Mujumdar U, et al. (2012) Vitamin D receptor gene haplotypes and polymorphisms and risk of breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev 21: 1856-1867.
  32. Liu D, Zhang H, Zou T, Zhang Y, Yang Z, et al. (2011) Association between the genetic polymorphisms of Vitamin D receptor and sporadic breast cancer risk in Yunnan women of Han nationality. Kunming Med Univer: 91–94.
  33. Anderson LN, Cotterchio M, Cole DE, Knight JA (2011) Vitamin D-related genetic variants, interactions with vitamin D exposure, and breast cancer risk among Caucasian women in Ontario. Cancer Epidemiol Biomarkers Prev 20: 1708-1717.
  34. Gapska P, Scott RJ, Serrano-Fernandez P, Huzarski T, Byrski T, et al. (2009) Vitamin D receptor variants and breast cancer risk in the Polish population. Breast Cancer Res Treat 115: 629-633.
  35. Chakraborty A, Mishra AK, Soni A, Regina T, Mohil R, et al. (2009) Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians. Cancer Detect Prev 32: 386-394.
  36. Abbas S, Nieters A, Linseisen J, Slanger T, Kropp S, et al. (2008) Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk. Breast Cancer Res 10: R31.
  37. McCullough ML, Stevens VL, Diver WR, Feigelson HS, Rodriguez C, et al. (2007) Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study. Breast Cancer Res 9: R9.
  38. John EM, Schwartz GG, Koo J, Wang W, Ingles SA (2007) Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population. Am J Epidemiol 166: 1409-1419.
  39. Sillanpaa P, Hirvonen A, Kataja V, Eskelinen M, Kosma VM, et al. (2004) Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk. Pharmacogenetics 14: 239-245.
  40. Buyru N, Tezol A, Yosunkaya-Fenerci E, Dalay N (2003) Vitamin D receptor gene polymorphisms in breast cancer. Exp Mol Med 35: 550-555.
  41. Newcomb PA, Kim H, Trentham-Dietz A, Farin F, Hunter D, et al. (2002) Vitamin D receptor polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev 11: 1503-1504.
  42. Hou MF, Tien YC, Lin GT, Chen CJ, Liu CS, et al. (2002) Association of vitamin D receptor gene polymorphism with sporadic breast cancer in Taiwanese patients. Breast Cancer Res Treat 74: 1-7.
  43. Cui J, Shen K, Shen Z, Jiang F, Shen F (2001) Relationship of vitamin D receptor polymorphism with breast cancer. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 18: 286-288.
  44. Lundin AC, Soderkvist P, Eriksson B, Bergman-Jungestrom M, Wingren S (1999) Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group. Cancer Res 59: 2332-2334.
  45. Dunning AM, McBride S, Gregory J, Durocher F, Foster NA, et al. (1999) No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer. Carcinogenesis 20: 2131-2135.
  46. Curran JE, Vaughan T, Lea RA, Weinstein SR, Morrison NA, et al. (1999) Association of A vitamin D receptor polymorphism with sporadic breast cancer development. Int J Cancer 83: 723-726.

Similar Articles

You may also start an advanced similarity search for this article.